Impact of the host genetic background on prognosis of chronic lymphocytic leukemia

Blood

Volumn 115, Issue 5, 2010, Pages 1106-1107

  Rasi, Silvia ^a   Forconi, Francesco ^b   Bruscaggin, Alessio ^a   Sozzi, Elisa ^b   Gaidano, Gianluca ^a   Rossi, Davide ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; CD38 ANTIGEN; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; INTERFERON REGULATORY FACTOR 4; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN MDM2; PROTEIN P53; BARD1 PROTEIN, HUMAN; DNA METHYLTRANSFERASE; FHL5 PROTEIN, HUMAN; IMMUNOGLOBULIN HEAVY CHAIN; MGMT PROTEIN, HUMAN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE;

ANTIGEN EXPRESSION; CANCER CHEMOTHERAPY; CANCER GENETICS; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; DNA DAMAGE; GENE DELETION; GENE MUTATION; HOST; IMMUNOGLOBULIN GENE; IMMUNOREGULATION; LETTER; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; SINGLE NUCLEOTIDE POLYMORPHISM; DISEASE FREE SURVIVAL; FOLLOW UP; GENE FREQUENCY; GENETICS; GENOTYPE; HUMAN; MORTALITY; NOTE; SURVIVAL RATE; TREATMENT OUTCOME;

DISEASE-FREE SURVIVAL; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FOLLOW-UP STUDIES; GENE FREQUENCY; GENOTYPE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; SURVIVAL RATE; TRANSCRIPTION FACTORS; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 77649221374     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-09-244335     Document Type: Letter

References (7)

1. Sellick GS, Wade R, Richards S, Oscier DG, Catovsky D, Houlston RS. Scan of 977 nonsynonymous SNPs in CLL4 trial patients for the identification of genetic variants influencing prognosis. Blood. 2008;111(3):1625-1633.
2. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 2002;30(17):3894-3900.
3. Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;31(13):3812-3814. (Pubitemid 37442253)
4. Aydin S, Rossi D, Bergui L, et al, CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome? Blood. 2008; 111(12):5646-5653.
5. Di Bernardo MC, Crowther-Swanepoel D, Broderick P, et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat Genet. 2008;40(10):1204-1210.
6. Gryshchenko I, Hofbauer S, Stoecher M, et al. MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia. J Clin Oncol. 2008; 26(14):2252-2257.
7. Benjamini Y, Hochberg Y. Controlling false discovery rate: a practicable and powerful approach to multiple testing. J R Stat Soc Br. 1995;57:289-300.